University of Cambridge > Talks.cam > Seminars on Quantitative Biology @ CRUK Cambridge Institute  > Circulating tumour DNA as a biomarker of genetics alterations in cancer

  Browse A-Z

Log in

Cambridge users (raven)details Other usersdetails No account?details

Information on

Subscribing to talksdetails Finding a talkdetails Adding a talkdetails Disseminating talksdetails Help and Documentationdetails

Circulating tumour DNA as a biomarker of genetics alterations in cancer

Add to your list(s) Download to your calendar using vCal

If you have a question about this talk, please contact Florian Markowetz.

Circulating tumour DNA as a biomarker of genetics alterations in cancer. Application to the quantitative determination of KRAS and BRAF mutations in plasma of colorectal cancer patients.

The pressing need to determine the KRAS mutational status for selecting patients with colorectal cancer for anti-EGFR therapy provides a great opportunity to use circulating tumor DNA (ctDNA) as a theranostic tool. However the determination of genetic alteration in ctDNA could benefit of a better knowledge of ctDNA, especially at the structural level.

We accumulated data on ctDNA structural characteristics enabling us to develop a specific ctDNA methodology. Intplex is based on Allele Specific Blocker Q-PCR, and consequently is simple, fast, and cost effective, and can discriminate targeted point mutation from even single copies of ctDNA. KRAS and BRAF mutations are driven mutations in CRC (colorectal cancer) and affect treatment outcome. Intplex was adapted to detect seven KRAS (G12V, G12D , G13D, G12S , G12A, G12C , G12R) and one BRAF V600E point mutations. KRAS and BRAF mutational status was determined with high concordance when comparing ctDNA analysis and conventional methods from tumor tissue section, and greater sensitivity (0.01% mutant/WT ratio).

We showed that CRC plasma analysis could replace advantageously tumour-section analysis of targeted point mutation and expand the scope of personalized medicine for cancer patients.

Hosted by Nitzan Rosenfeld

This talk is part of the Seminars on Quantitative Biology @ CRUK Cambridge Institute series.

Tell a friend about this talk:

This talk is included in these lists:

Note that ex-directory lists are not shown.

Other lists

Philosophy and Natural Philosophy in the Early Modern Period ICE Research Seminar Series Lister Institute Research Prize Fellowship Talks Cambridge University Armenian Society FERSA Guest Lectures Forum for Youth Participation and Democracy

Other talks

The Rise of Augmented Intelligence in Edge Networks A V HILL LECTURE - The cortex and the hand of the primate: a special relationship Streptococcus suis - managing a global zoonotic pathogen of pigs "Vectorbuilder: Revolutionising Vector Design & Custom Cloning" (25 min seminar) followed by "Advanced Technologies For Rapid Generation Of Custom Designed Animal Models" (25 min seminar) Deterministic RBF Surrogate Methods for Uncertainty Quantification, Global Optimization and Parallel HPC Applications Cambridge-Lausanne Workshop 2018 - Day 1 'Walking through Language – Building Memory Palaces in Virtual Reality' Computing High Resolution Health(care) Unbiased Estimation of the Eigenvalues of Large Implicit Matrices Constructing the virtual fundamental cycle A new proposal for the mechanism of protein translocation The Move of Economics Ideas and Numbers into Policy
 

© 2006-2024 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity